Patient has a BMI (body mass index) of 30 or higher, or
Before starting GLP-1 therapy , patients should discuss their complete medical history with their healthcare provider, including the duration and stability of their Hashimoto's disease, current levothyroxine dose, most recent thyroid function tests, and any family history of thyroid cancer or MEN 2 syndrome
[13] In the other five trials (NCT01930188, [71] NCT01885208, [72] NCT02128932, [73] NCT02207374, [74] and NCT02254291 [75] ), participants were randomly assigned to receive either semaglutide or another anti-diabetic medication, and the participant and provider knew which medication was being given in four trials
44,6), comprised more males (66% vs